RA Treatment Strategies

Clifton Bingham, M.D. - Jon Giles, M.D.

Abstract 657: Evidence for a Window Of Opportunity in a Double-Blind Randomized Clinical Trial in Patients with Undifferentiated Arthritis: The Probable Rheumatoid Arthritis: Methotrexate Versus Placebo Treatment (the Prompt)-Study

658. Remission Induction in Early Rheumatoid Arthritis (RA) with Initial Infliximab (IFX) and Methotrexate (MTX) Therapy: The Disease Course After IFX Discontinuation in The BeSt Trial

Abstract 1306: Induction of Remission in Patients with Early Rheumatoid Arthritis (RA) Initially Treated with Either Prednisone or Infliximab Combination Therapy

Abstract 1308: A Randomised Controlled Trial of Step Up Therapy Versus Triple Therapy In Early Active Rheumatoid Arthritis - The TEAR Study

Abstract 1309: Does Addition of Infliximab to Triple DMARD Plus Prednisolone Therapy Increase Rate of Remissions in Patients with Early Active Rheumatoid Arthritis? A Randomized Double-Blind Placebo-Controlled Study

L43. The Efficacy and Safety of Abatacept or Infliximab in RA Patients with an Inadequate response to MTX: Results from a 1-year Double-blind, Randomized, Placebo-controlled Trial

footer line

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.